bimagrumab and tirzepatide plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial Pharmacologic Treatments for the Preservation

For Wegovy dosages, the injectable versions doses are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, and 7.2 mg

Retatrutide at lower doses (2-4mg) combined with a slight caloric deficit or maintenance calories and a structured resistance training program creates conditions favorable for recomposition

Ann Surg 252(5):744-9, 2010

It immediately goes to work in the cytosol, binding to methionine synthase and rapidly converting toxic homocysteine into beneficial methionine

Sander, P., Gudermann, T

Some patients experience a non-linear pattern: tolerable symptoms at 5 mg, severe symptoms at 7.5 mg, then improvement again at 10 mg